Despite years of frustration that pharmacogenomic testing for antiplatelet therapy dosing has not been adopted as hoped in the field of cardiology, new evidence is emerging that genetic testing should … [Read more...]
GENETIC TESTING
Inside the Diagnostics Industry: Genotyping to Guide Antiplatelet Selection Feasible, Effective
April 24, 2018
SAFETY
Diagnostic danger in the lab: Time to reform how we process orders
April 16, 2018
By Oleg Bess, M.D. bio I don't know about you, but I was stunned by the findings from a recent report published by Coverys, a national liability insurer, which I feel should put the entire … [Read more...]
GENETIC TESTING
Tests Emerging to Advance Cardiovascular Risk Assessment
March 26, 2018
While testing for cardiovascular conditions does not garner the headlines that oncology testing does, several recent studies demonstrate how the introduction of genetic testing and other new testing … [Read more...]
ANNUAL SURVEY
Outreach Survey Focuses on Clinical Laboratory Industry Trends Amidst Greatest Disruption in Three Decades
March 12, 2018
By Jeff Myers bio Accumen Inc. is pleased to announce the launch of the 17th Annual National Hospital and Health System Laboratory and Outreach Survey. The survey is designed to capture … [Read more...]
INDUSTRY TRENDS
FDA’s Two Big Moves on NGS-Based Tumor Panels May Offer Clues for Alternative Pathways for LDT Approval
January 8, 2018
In late November the U.S. Food and Drug Administration (FDA) authorized Memorial Sloan Kettering Cancer Center's Integrated Mutation Profiling of Actionable Cancer Targets tumor profiling test assay … [Read more...]
INDUSTRY TRENDS
Inside the Diagnostics Industry: Laboratory Data Core to Value-Based Health Care
December 4, 2017
To thrive in the present challenging environment, laboratories need to deliberately focus on how they can create value outside of their own walls. The key to achieving this is in their data. Speakers … [Read more...]
INDUSTRY TRENDS
Diagnostics Industry Responding to Opioid Epidemic
October 23, 2017
Prescription opioids are among the most common drugs prescribed and are the most effective treating for pain, whether it is debilitating, chronic pain or temporary pain, such as after surgery. While … [Read more...]
INDUSTRY TRENDS
Curetis to Launch Multiplex MDx for Hospital Infections in U.S.
September 18, 2017
Molecular diagnostics firm Curetis (Germany) specializes in solutions to rapidly diagnose and profile antibiotic resistance for severe infections in hospitalized patients. The company currently has … [Read more...]
NEWS
Testing Guidelines at a Glance
September 12, 2017
The American Society of Clinical Oncology (ASCO) published updated practice guidelines Aug. 14 in the Journal of Clinical Oncology regarding the use of targeted immunotherapy for patients with stage … [Read more...]
NEWS
Inside the Diagnostics Industry: At-Home Testing Options Expanding
August 17, 2017
There is a proliferation of companies offering at-home testing. In some cases these are mail-in tests where patients collect their own samples (blood, mouth swab, urine, or stool) and mail them into a … [Read more...]
